Gil-Vila, A. Et Al. 2022. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies. Muscle and Nerve , vol.66 , 426-437.

Gil-Vila, A., Ravichandran, N., Selva-O'Callaghan, A., Sen, P., Nune, A., Gaur, P. S., ... Gonzalez, R. A.(2022). COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies. Muscle and Nerve , vol.66, 426-437.

Gil-Vila, Albert Et Al. "COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies," Muscle and Nerve , vol.66, 426-437, 2022

Gil-Vila, Albert Et Al. "COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies." Muscle and Nerve , vol.66, pp.426-437, 2022

Gil-Vila, A. Et Al. (2022) . "COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies." Muscle and Nerve , vol.66, pp.426-437.

@article{article, author={Albert Gil-Vila Et Al. }, title={COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies}, journal={Muscle and Nerve}, year=2022, pages={426-437} }